Your browser doesn't support javascript.
loading
Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians.
Chazan, G; Franchini, F; Alexander, M; Banerjee, S; Mileshkin, L; Blinman, P; Zielinski, R; Karikios, D; Pavlakis, N; Peters, S; Lordick, F; Ball, D; Wright, G; IJzerman, M; Solomon, B J.
Afiliação
  • Chazan G; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
  • Franchini F; Centre for Cancer Research and Centre for Health Policy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia; Melbourne School of Public and Global Health, Faculty of Medicine, Dentistry and Health Sciences, Parkville, Australia; Department of Cancer Res
  • Alexander M; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia; Department of Pharmacy, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK; Division of Clinical Studies, The Institute of Cancer Research, London, UK.
  • Mileshkin L; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Blinman P; Faculty of Medicine, University of Sydney, Sydney, Australia; Medical Oncology, Concord Repatriation General Hospital, Concord, Australia.
  • Zielinski R; Medical Oncology, Western Sydney University, Sydney, Australia; Medical Oncology, Orange Hospital, Western New South Wales Local Health District, Orange, Australia.
  • Karikios D; Medical Oncology, Nepean Hospital, Sydney, Australia; Nepean Clinical School, University of Sydney, Sydney, Australia.
  • Pavlakis N; Medical Oncology, Royal North Shore Hospital, Sydney, Australia.
  • Peters S; Medical Oncology, Lausanne University Hospital CHUV, Lausanne, Switzerland.
  • Lordick F; University Cancer Centre Leipzig, University Medicine Leipzig, Leipzig, Germany.
  • Ball D; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia; Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Wright G; St Vincent's Hospital, Victorian Comprehensive Cancer Centre, Fitzroy, Australia; Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Surgery, University of Melbourne, Parkville, Australia.
  • IJzerman M; Centre for Cancer Research and Centre for Health Policy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia; Department of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia; University of Twente, Health Technology & Services Resea
  • Solomon BJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: Ben.solomon@petermac.org.
ESMO Open ; 6(5): 100224, 2021 10.
Article em En | MEDLINE | ID: mdl-34461484
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália